arimoclomol has been researched along with Retinitis Pigmentosa in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguila, M; Athanasiou, D; Bevilacqua, D; Cheetham, ME; Coffey, PJ; Greensmith, L; Kalmar, B; Kanuga, N; McCulley, CH; Mendes, HF; Munro, PM; Novoselov, SS; Parfitt, DA | 1 |
1 other study(ies) available for arimoclomol and Retinitis Pigmentosa
Article | Year |
---|---|
The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa.
Topics: Animals; Cell Line; Cell Survival; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Heat-Shock Response; Humans; Hydroxylamines; Mutation; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Retinal Degeneration; Retinitis Pigmentosa; Rhodopsin; Time Factors; Transfection; Unfolded Protein Response; Vision, Ocular | 2014 |